Abstract:Background— Left ventricular assist device (LVAD) is being increasingly used in patients with end-stage dilated and ischemic cardiomyopathy. There have been no clinical trials addressing the use of LVAD therapy in patients with end-stage heart failure caused by restrictive (RCM) or hypertrophic cardiomyopathy (HCM). The purpose of this study was therefore to analyze the outcome of LVAD therapy in these patients. Methods and Results— Eighty-three patients received continuous axial flow LVAD (Heart mate II, Thoratec, Pleasanton, CA) from February 2007 to May 2010 at our institution. We analyzed the baseline characteristics and surgical and long-term impact of LVAD therapy in 8 patients with RCM or HCM and compared their outcomes with the 75 patients with dilated and ischemic cardiomyopathy. Compared with patients with ischemic or dilated cardiomyopathy, patients with RCM and HCM have significantly smaller left ventricular end-diastolic dimensions (52.5±6 mm versus 68.6±8 mm; P <0.0001) and increased thickness of septal (16 [12, 19] mm versus 10[8.5, 11] mm, P =0.0003) and higher left ventricular ejection fraction (21 [20, 36]% versus 17 [15, 22]%; P =0.0009). We found no difference in early mortality (12.5% versus 9.3%, P =0.57) or length of hospital stay (11 [8, 45] days versus 18.5 [12.2, 27.7] days; P =0.51) between the 2 groups. The right atrial pressure was higher (18 [15, 20] mm Hg versus 12 [9, 15] mm Hg, P =0.03), and pump flow was lower (4.3 [3.8, 4.5] L versus 5.2 [4.7, 5.5] L, P =0.001) after LVAD implantation in patients with RCM and HCM. Central venous catheter related infections were more common in patients with RCM and HCM (87.5% versus 44.5%, P =0.006). There was no difference in the total number of blood units transfused. Median (min, max) follow-up duration after LVAD implantation was 166 [1, 1044] days. The 1-year actuarial survival rate was not different between the 2 groups (87.5% [95% confidence interval, 52.9% to 97.8%] versus 73.2 [95% confidence interval, 60% to 85%]; P =0.77). Conclusions— Our preliminary data show that patients with end-stage heart failure caused by RCM or HCM may benefit from continuous axial flow LVAD therapy. This small study suggests that mortality is comparable with those patients who have dilated or ischemic cardiomyopathy, but right heart failure, prolonged inotropic use, and central venous catheter infections are more common in patients with RCM and HCM who were treated with LVAD. Because of the small numbers the differences should be interpreted cautiously, and prospective clinical trials would be required to recommend this therapy for these patients as bridge to transplantation or destination treatment.

Partial Left Ventriculectomy to Treat End-Stage Heart Failure

Clinical Effect of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure

Selective Interventricular Septal Radiofrequency Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?

Valve Replacement for Valvular Heart Disease with Giant Left Ventricle.

Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy

TCT-387 Short- and Long-term Outcomes of Coronary Revascularization in Patients with Severe Left Ventricular Dilatation

Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Severe Left Ventricular Dilatation

The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy

Long-term effectiveness of biventricular pacing therapy in patients with congestive heart failure of different etiology

Short-term study of atrial shunt and improvement of functional mitral regurgitation

Initial Clinical Experience with Implantation of a New Left Ventricular Assist Device HeartCon

Non-heart transplant surgical approaches with left ventricular restoration and mitral valve operation for advanced ischaemic cardiomyopathy

The Personal Treatment for Patients with Double Outlet of Fight Ventricle

CH‐VAD left ventricular assist implantation combined with the Bentall procedure and coronary artery bypass grafting

Early left bundle branch pacing in heart failure with mildly reduced ejection fraction and left bundle branch block

Outcomes of off-pump versus on-pump coronary artery bypass graft surgery in patients with severely dilated left ventricle.

Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device

Postoperative care of 14 patients with left ventricular assist devices: a case series

[Myocardial Revascularization among Patients with Severe Left Ventricular Dysfunction: a Comparison Between On-Pump Beating-Heart and Off-Pump Coronary Artery Bypass Grafting].